Astrocytoma, IDH-Mutant, Grade 3
generalIDH-mutant astrocytoma characterized by the presence of necrosis and/or microvascular proliferation or homozygous deletion of CDKN2A and/or CDKN2B genes. The term glioblastoma no longer applies to central nervous system WHO grade 4 IDH-mutant astrocytomas. (WHO 2021)
37
Centers
47
Active Trials
$3.3B
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Recurrent Astrocytoma, IDH-Mutant, Grade 4 | 18 |
Top Centers for Astrocytoma, IDH-Mutant, Grade 3(37)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center | 71.8 |
| 2 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive High-Volume Research Center | 71.8 |
| 3 | Boston University Cancer CenterBoston, MA High-Volume Research Center | 71.8 |
| 4 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 49.3 |
| 5 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 49.3 |
| 6 | NCI Comprehensive Active Research Program | 49.3 |
| 7 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 49.3 |
| 8 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 49.3 |
| 9 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 49.3 |
| 10 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 49.3 |
| 11 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 49.3 |
| 12 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 49.3 |
| 13 | NCI Comprehensive Active Research Program | 49.3 |
| 14 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 49.3 |
| 15 | NCI Comprehensive Active Research Program | 49.3 |
| 16 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 49.3 |
| 17 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 49.3 |
| 18 | NCI Clinical Active Research Program | 49.3 |
| 19 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 49.3 |
| 20 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 49.3 |
| 21 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 49.3 |
| 22 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 49.3 |
| 23 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 49.3 |
| 24 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 49.3 |
| 25 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 49.3 |
| 26 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 49.3 |
| 27 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive | — |
| 28 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | — |
| 29 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | — |
| 30 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | — |
| 31 | NCI Comprehensive | — |
| 32 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | — |
| 33 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | — |
| 34 | NCI Comprehensive | — |
| 35 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive | — |
| 36 | University of Illinois Cancer CenterChicago, IL | — |
| 37 | Cancer Center at IllinoisUrbana, IL | — |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →